Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.260
+0.020 (0.62%)
At close: Dec 19, 2025, 4:00 PM EST
3.390
+0.130 (3.99%)
After-hours: Dec 19, 2025, 7:57 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $36.46 million as of December 19, 2025. Its market cap has decreased by -11.73% in one year.
Market Cap
36.46M
Enterprise Value
24.19M
1-Year Change
-11.73%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $36.46M, an increase of 20.22%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 36.46M | 5.98% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |